Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine oral liquid study in children with hypertension
NL-OMON41645Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of amlodipine in hypertension (HTN), sponsored by Erasmus MC. Primary endpoint: Pharmacokinetic parameters of amlodipine oral solution. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON41645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41645.